Free Web NovelChapter 696: Chapter 385: What can medical research achieve?
After checking the results of a few experiments conducted by Li Ming and Zhang Wei, Zhao Yi decided to focus on the metabolic reactions in E. Coli bacteria, more specifically, studying the reactions between E. Coli and antibodies, and how E. Coli gets digested by the immune system.
However, there had been no progress in their group’s research in the past few months.
On average, every one to two days, Zhao Yi would visit the lab to check on the experiments and data. Although he didn’t find any new results, he maintained a positive mentality.
Even though there hadn’t been any progress for a while, this is common in most studies. It’s not unusual to see a study without any progress for one or two months or even a year, and it’s not out of the ordinary for studies to be put on hold indefinitely.
But the team was hoping to see some results.
Firstly, the prospect of drug development was indeed promising, as it is a major project directly connected with pharmaceutical companies, involving many interests.
Secondly, there is the aspect of comparison.
The group of Han Hui and Ai Lixin, which focused on research around replicating the human immune environment, was rolling out one result after another. They had managed to reduce the cost of producing the 2CV-Bing Hydrogen Molecule in a simulated human environment to about a third of the original cost.
This success could be described as outstanding.
The pharmaceutical companies were satisfied with the cost reduction in the experimental environment because the same efforts in research and development would result in a significant reduction in experimental costs.
If they couldn’t find a method of mass-producing the 2CV-Bing Hydrogen Molecule in a short period of time, reducing experimental production costs could be an alternative choice, although it would result in high drug prices after market approval.
Additionally, the R&D center of the pharmaceutical company had moved into the ’drug testing’ phase.
They found ten AIDS patients to inject a certain amount of 2CV-Bing Hydrogen Molecule weekly to observe the spread of the AIDS virus within their bodies.
If they can confirm that the 2CV-Bing Hydrogen Molecule had a good therapeutic effect and couldn’t find a method for mass production in the short term, the pharmaceutical company may choose to produce drugs based on the 2CV-Bing Hydrogen Molecule under experimental conditions despite the high cost.
This was an unavoidable choice.
The 2CV-Bing Hydrogen Molecule is not a new substance. If even a bit of news leaks, others would know, and extending the timeline of the R&D process would present a big problem for confidentiality.
After thorough evaluation, they decided to reduce the experimental cost for production, which would at least enable the drug to go on the market. Even though the selling price would be extremely high, its effectiveness would still attract many people.
Therefore, the work done by Han Hui and Ai Lixin’s group in reducing the cost of a simulated human testing environment is very meaningful.
Things were going relatively well for the group led by Han Hui and Ai Lixin. They had quite a few breakthroughs, but both Han Hui and Ai Lixin were not people who boast about their achievements. They only report their progress quietly during regular meetings.
However, Dai Tianqing’s group was different.
Dai Tianqing and Chen Zhigang’s group was doing research into the immune response of vertebrate mammals to bacteria, hoping to find small protein molecules that could replace the 2CV-Bing Hydrogen Molecule, or hoping to make other discoveries.
This was indeed a good approach.
The 2CV-Bing Hydrogen Molecule is a small protein molecule produced by the immune system in response to bacteria. Other vertebrate mammals may also produce similar small protein molecules in response.
Dai Tianqing’s group quickly made a discovery. They extracted from the blood of a robust chimpanzee a small protein molecule similar to the 2CV-Bing Hydrogen Molecule. However, tests showed that this small protein molecule had virtually no impact on resisting the AIDS virus.
"Perhaps it’s because chimpanzees naturally have strong resistance to the AIDS virus."
Many people came to this conclusion after hearing the results. ƒгeewebnovёl.com
Although the discovery wasn’t significant, it gave people hope. Dai Tianqing seemed to see potential in the research, and kept saying, "I believe our group will make a big discovery soon."
"Zhao Yi, would you like to join my group?"
"Old Ai, I believe you’ve made a mistake by sticking with that old hag Han Hui!"
"Zhang Wei, don’t worry, you were my protege after all. When it comes time to publish our research, I’ll make sure to look after you."
"..."
Every time Zhao Yi saw Dai Tianqing, he felt an urge to kick him in the face.
Zhang Wei was somewhat better. At least she was on the receiving end of the care, giving a quiet smile and politely expressing her thanks, but she must be quite uncomfortable deep down.
As for Li Ming...
As someone sitting in a corner being ignored, he could only think about taking the blood of people in Dai Tianqing’s lab and making sure to jab the first needle forcefully into a nerve line.
In short, everyone in Zhao Yi’s group felt depressed.
So, when Zhao Yi learned that a new discovery had been made in the experiment, he immediately put down his research work and rushed to the lab.
"Over here!"
"It’s this one, the third test slot." Zhang Wei yelled from inside her white lab coat behind the glass window.
After disinfecting and putting on his lab coat, Zhao Yi went in and stood in front of the third test slot, observing the mixed substance inside.
Zhang Wei explained, "A few days ago, Director Han Hui submitted a new detection method that targets E. Coli that has been marked by antibodies. It can be used to determine how much E. Coli has been marked."
"We tested this method and found that the E. Coli in this test slot, which is also the fourth generation, displayed less marked proportions than other test slots after being injected with the same bacterial antibodies."
